BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chamakuri S, Lu S, Ucisik MN, Bohren KM, Chen YC, Du HC, Faver JC, Jimmidi R, Li F, Li JY, Nyshadham P, Palmer SS, Pollet J, Qin X, Ronca SE, Sankaran B, Sharma KL, Tan Z, Versteeg L, Yu Z, Matzuk MM, Palzkill T, Young DW. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors. Proc Natl Acad Sci U S A 2021;118:e2111172118. [PMID: 34426525 DOI: 10.1073/pnas.2111172118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Modukuri RK, Monsivais D, Li F, Palaniappan M, Bohren KM, Tan Z, Ku AF, Wang Y, Madasu C, Li JY, Tang S, Miklossy G, Palmer SS, Young DW, Matzuk MM. Discovery of Highly Potent and BMPR2-Selective Kinase Inhibitors Using DNA-Encoded Chemical Library Screening. J Med Chem 2023. [PMID: 36719862 DOI: 10.1021/acs.jmedchem.2c01886] [Reference Citation Analysis]
2 Shell DJ, Rectenwald JM, Buttery PH, Johnson RL, Foley CA, Guduru SKR, Uguen M, Rubiano JS, Zhang X, Li F, Norris-Drouin JL, Axtman M, Brian Hardy P, Vedadi M, Frye SV, James LI, Pearce KH. Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library. SLAS Discov 2022;27:428-39. [PMID: 36272689 DOI: 10.1016/j.slasd.2022.10.003] [Reference Citation Analysis]
3 de Wispelaere M, Yang PL. Targeted Protein Degradation in Antiviral Drug Discovery. Protein Homeostasis in Drug Discovery 2022. [DOI: 10.1002/9781119774198.ch14] [Reference Citation Analysis]
4 Janin YL. On drug discovery against infectious diseases and academic medicinal chemistry contributions. Beilstein J Org Chem 2022;18:1355-78. [DOI: 10.3762/bjoc.18.141] [Reference Citation Analysis]
5 Xu H, Tan T, Zhang Y, Wang Y, Pan K, Yao Y, Zhang S, Gu Y, Chen W, Li J, Dong H, Meng Y, Ma P, Hou W, Yang G. Metal‐Free and Open‐Air Arylation Reactions of Diaryliodonium Salts for DNA‐Encoded Library Synthesis. Advanced Science. [DOI: 10.1002/advs.202202790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Moghadasi SA, Esler MA, Otsuka Y, Becker JT, Moraes SN, Anderson CB, Chamakuri S, Belica C, Wick C, Harki DA, Young DW, Scampavia L, Spicer TP, Shi K, Aihara H, Brown WL, Harris RS. Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M(pro)/3CL(pro) in Living Cells. mBio 2022;13:e0078422. [PMID: 35471084 DOI: 10.1128/mbio.00784-22] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Siripuram VK, Sunkari YK, Nguyen T, Flajolet M. DNA-Compatible Suzuki-Miyaura Cross-Coupling Reaction of Aryl Iodides With (Hetero)Aryl Boronic Acids for DNA-Encoded Libraries. Front Chem 2022;10:894603. [DOI: 10.3389/fchem.2022.894603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang R, Oerlemans R, Wang C, Zhang L, R. Groves M. Drug Repurposing Techniques in Viral Diseases. Drug Repurposing - Molecular Aspects and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.101443] [Reference Citation Analysis]
9 Malla TR, Brewitz L, Muntean DG, Aslam H, Owen CD, Salah E, Tumber A, Lukacik P, Strain-Damerell C, Mikolajek H, Walsh MA, Schofield CJ. Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine. J Med Chem 2022. [PMID: 35549342 DOI: 10.1021/acs.jmedchem.1c02214] [Reference Citation Analysis]
10 Fang X, Wang Y, He P, Liao H, Zhang G, Li Y, Li Y. Visible Light-Promoted Divergent Benzoheterocyclization from Aldehydes for DNA-Encoded Chemical Libraries. Org Lett 2022. [PMID: 35467894 DOI: 10.1021/acs.orglett.2c01187] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Rossetti GG, Ossorio MA, Rempel S, Kratzel A, Dionellis VS, Barriot S, Tropia L, Gorgulla C, Arthanari H, Thiel V, Mohr P, Gamboni R, Halazonetis TD. Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits. Sci Rep 2022;12:2505. [PMID: 35169179 DOI: 10.1038/s41598-022-06306-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
12 Xu S, Ding D, Zhang X, Sun L, Kang D, Huang B, Liu X, Zhan P. Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary. Molecules 2022;27:850. [PMID: 35164129 DOI: 10.3390/molecules27030850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Narayanan A, Toner SA, Jose J. Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases. Biochem Soc Trans 2022:BST20211180. [PMID: 35015073 DOI: 10.1042/BST20211180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gui Y, Li X. Selection Strategies in DNA-Encoded Libraries. Topics in Medicinal Chemistry 2022. [DOI: 10.1007/7355_2022_149] [Reference Citation Analysis]